Spinal fluid biobank aims to unlock secrets of rare childhood brain disorders
NCT ID NCT07313098
First seen Jan 08, 2026 · Last updated Jun 23, 2026 · Updated 26 times
Summary
This study will collect and analyze cerebrospinal fluid from 1,000 children with various neurological conditions, such as traumatic brain injury or hydrocephalus. Researchers will look for protein markers that could help diagnose and track these diseases more accurately. The goal is to build a biobank that can be used for future research, especially for rare pediatric brain disorders where data is currently limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROLOGIC DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Necker-Enfants malades
Paris, 75015, France
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to better diagnostic tools and biomarkers for rare neurological diseases in children, improving early detection and treatment monitoring.
What could go wrong
This is an observational study that does not test a treatment, so it will not directly benefit participants. The findings may not translate into clinical practice for years, if at all.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.